- $162.53m
- $134.46m
- $55.22m
- 85
- 14
- 52
- 49
Annual income statement for CSP, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 61.8 | 49.2 | 54.4 | 64.6 | 55.2 |
| Cost of Revenue | |||||
| Gross Profit | 17.2 | 16.1 | 18.8 | 21.9 | 18.9 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 63.2 | 48.4 | 54.4 | 62.8 | 57.1 |
| Operating Profit | -1.42 | 0.834 | -0.04 | 1.87 | -1.87 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -1.06 | 0.678 | 1.94 | 4.74 | -0.419 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1.45 | 0.234 | 1.89 | 5.2 | -0.326 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -1.45 | 0.699 | 1.89 | 5.2 | -0.326 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -1.45 | 0.699 | 1.79 | 4.88 | -0.326 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.179 | -0.144 | 0.209 | 0.546 | -0.036 |
| Dividends per Share |